Status:
COMPLETED
Evaluation of Factors in Human Brain Tumors
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Brain Neoplasm
Glioblastoma
Eligibility:
All Genders
Brief Summary
Presently, patients with primary malignant brain tumors have a life expectancy of 15 weeks following surgery unless they receive additional types of therapy (chemotherapy, radiotherapy, and/or immunot...
Detailed Description
This protocol involves the study of human brain tumor cells outside the body in the laboratory as part of an attempt to better understand these tumors and to develop more effective therapeutic measure...
Eligibility Criteria
INCLUSION CRITERIA:
Patients to be studied will have either undergone surgical confirmation of a malignant primary brain tumor or be considered likely to have that diagnosis on the basis of diagnostic studies.
They should have survival likelihood of at least three months and be able to comprehend the nature of the proposed program.
Key Trial Info
Start Date :
July 1 1979
Trial Type :
OBSERVATIONAL
End Date :
September 1 2005
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00001171
Start Date
July 1 1979
End Date
September 1 2005
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States, 20892